A number of cancer vaccines are now entering the final stage of clinical development. Are vaccines finally on their way to enjoying mainstream success in the oncology arena?
Cancer vaccines edge towards success
Richard Harrop and Stuart Naylor
Related Articles
Impact Factor
Dropping bars or rising hoops phase III outcomes of NSCLC
Drug Watch
PHARE: shining a light for academic research in Europe
Editorial
Leave a Reply